DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Niludipine
Niludipine
(12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
Method and Compositions for the Treatment of Tumors Comprising a Calcium Channel Blocker Compound of the Dlhydropyridlne Class and a Platinum Coordination Compound
Ovid MEDLINE(R)
Phase II Trial of VELCADE® (Bortezomib)
Marrakesh Agreement Establishing the World Trade Organization
Sustained-Release Dihydropyridine Formulation
Drug Delivery System for Use in the Treatment Or Diagnosis of Neurological Disorders
Dihydropyridine Receptor in Rat Brain Labeled With
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Quantitative Structure-Interaction Relationship Analysis of 1,4-Dihydropyridine Drugs in Concomitant Administration with Grapefruit Juice
Quantitative Structure-Interaction Relationship Analysis of 1,4-Dihydropyridine Drugs in Concomitant Administration with Grapefruit Juice
Circumvention of Vincristine and Adriamycin Resistance in Vitro and in Vivo by Calcium Influx Blockers1
CUSTOMS TARIFF - SCHEDULE 99 - I
Privileged Communication Nabtc-9705
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Combination of Dofetilide and a Calcium Channel Blocker
The Rationale of Using Calcium Antagonists in the Treatment of Ischaemic Heart Disease
Top View
Marrakesh Agreement Establishing the World Trade Organization
Amendment Protocol Number: 09C0195-X Reference Number: 365264
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Downloaded for Personal Non-Commercial Research Or Study, Without Prior Permission Or Charge
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
1, 4-Dihydropyridines: the Multiple Personalities of A
(12) Patent Application Publication (10) Pub. No.: US 2003/0199551A1 Dreyer (43) Pub
||||||IIII USO05506231A United States Patent (19) 11 Patent Number: 5,506,231 Lipton 45 Date of Patent: Apr
(12) Patent Application Publication (10) Pub. No.: US 2010/0226943 A1 Brennan Et Al
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
A Phase II Study of Pazopanib with Oral Topotecan in Patients with Metastatic and Non-Resectable Soft Tissue and Bone Sarcomas
(12) Patent Application Publication (10) Pub. No.: US 2010/0305135 A1 Garbaccio Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Nimodipine* (Calcium Antagonists/Binding Site/Structural Specificity/Stereoselectivity/Cerebrovascular Diseases) P
Ligand P-Gp Inhibition
Harmonized Tariff Schedule of the United States (2006) (Rev
Suppression by Orally-Administered
Role of Calcium in Luteinization Stimulator-Enhanced Progesterone Production of Porcine Granulosa Cells
(12) United States Patent (10) Patent No.: US 6,268,377 B1 Waldstreicher Et Al
(12) Patent Application Publication (10) Pub. No.: US 2009/0247582 A1 Webb (43) Pub
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri